Tilray (NASDAQ:TLRY) Trading Up 2.9%

Tilray Inc (NASDAQ:TLRY) shares rose 2.9% during mid-day trading on Monday . The company traded as high as $2.22 and last traded at $2.16. Approximately 15,613,772 shares were traded during trading, a decline of 50% from the average daily volume of 31,006,447 shares. The stock had previously closed at $2.10.

Analyst Ratings Changes

A number of research analysts have weighed in on the company. Alliance Global Partners lifted their target price on Tilray from $2.25 to $2.75 and gave the company a “neutral” rating in a report on Friday, April 5th. CIBC lowered their target price on shares of Tilray from $2.25 to $2.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 10th. Finally, Canaccord Genuity Group reduced their price objective on Tilray from $4.25 to $4.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th.

Tilray Trading Down 1.5 %

The company has a quick ratio of 1.18, a current ratio of 1.92 and a debt-to-equity ratio of 0.11. The firm’s 50-day simple moving average is $1.99 and its 200-day simple moving average is $1.94. The firm has a market capitalization of $1.51 billion, a PE ratio of -4.43 and a beta of 2.36.

Institutional Investors Weigh In On Tilray

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Clear Street Markets LLC purchased a new position in Tilray during the 3rd quarter valued at about $25,000. Gainplan LLC bought a new position in Tilray in the 4th quarter worth about $28,000. Simplicity Wealth LLC bought a new stake in Tilray during the 1st quarter valued at about $28,000. RPO LLC bought a new position in shares of Tilray in the fourth quarter worth approximately $28,000. Finally, Great Valley Advisor Group Inc. purchased a new stake in shares of Tilray during the third quarter valued at approximately $29,000. 9.35% of the stock is currently owned by institutional investors.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.